Author

Silvio Danese 1

1 Istituto Clinico Humanitas,Milan,Italy

European Consensus on the Diagnosis and Management of Iron Deficiency and Anaemia in Inflammatory Bowel Diseases

Axel Dignass, Christoph Gasché, Dominik Bettenworth, Gunnar Birgegard, Silvio Danese, Javier Gisbert, Fernando Gomollon Garcia, Tariq Iqbal, Konstantinos H. Katsanos, Ioannis Koutroubakis, Fernando Jose Magro Dias, Guillaume Savoye, Jürgen Stein, Stephan Vavricka

CORRELATION OF BIOMARKERS OF INFLAMMATION WITH CLINICAL AND ENDOSCOPIC ENDPOINTS IN PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE: DATA FROM CELEST

Jean-Frederic Colombel, Laurent Peyrin-Biroulet, Silvio Danese, Simon Travis, Gerald Dryden, Robert Hardi, Michael S Epstein, Wen Zhou, Fabio Cataldi, Bidan Huang, Ana Paula Lacerda, Julian Panés

Corticosteroid Sparing Effects of Ustekinumab Therapy in Ulcerative Colitis Patients: Results From the UNIFI Program

Silvio Danese, Bruce E. Sands, Laurent Peyrin-Biroulet, C Marano, Christopher O’Brien, Hongyan Zhang, Alessandra Nunes Faria Oortwijn, David Rowbotham, Rupert W Leong, Ramesh P. Arasaradnam, Gert Van Assche, William Sandborn, Remo Panaccione

BUDESONIDE MMX® EFFICACY IS INDEPENDENT OF PREVIOUS MESALAZINE EXPOSURE IN ULCERATIVE COLITIS: POOLED ANALYSIS OF CORE I AND CORE II

Silvio Danese, Limas Kupcinskas, E. David Ballard, Raul Harris-Collazo, Yun Hardiman, Michael Huang, Simon Travis

Assessment of Budesonide MMX® effectiveness for active, mild-to-moderate ulcerative colitis in the Polish sub-group of the prospective multi-center observational study CORE Practice

Grażyna Rydzewska, Kristine Paridaens, Silvio Danese, Maciej Jesionowski

COMPARATIVE ACCURACY OF BOWEL ULTRASOUND VERSUS MAGNETIC RESONANCE ENTEROGRAPHY AND COLONOSCOPY IN ASSESSING DISEASE ACTIVITY AND COMPLICATIONS AND INFLUENCING THE DECISION-MAKING PROCESS IN CROHN’S DISEASE

Mariangela Allocca, Gionata Fiorino, Cristiana Bonifacio, Federica Furfaro, Daniela Gilardi, Simona Radice, Laurent Peyrin-Biroulet, Silvio Danese

High versus standard adalimumab induction dosing regimens in patients with moderately to severely active ulcerative colitis: results from the SERENE-UC induction study

Julian Panés, Jean-Frederic Colombel, Geert R. D'Haens, Stefan Schreiber, Remo Panaccione, Laurent Peyrin-Biroulet, Edward Loftus, Jr, Silvio Danese, Edouard Louis, Alessandro Armuzzi, Marc Ferrante, Harald Vogelsang, Jessica Lefebvre, Thao Doan, Nisha V. Kwatra, Nael M. Mostafa, Wangang Xie, Bidan Huang, Joel Petersson;;

Histologic Improvement With Vedolizumab vs Adalimumab in Ulcerative Colitis: Results From VARSITY

Laurent Peyrin-Biroulet, Jean-Frederic Colombel, Edward Loftus, Jr, Silvio Danese, Brihad Abhyankar, Jingjing Chen, Raquel Rogers, Richard A. Lirio, Jeffrey Bornstein, Bruce E. Sands, Stefan Schreiber

Long-term mucosal healing, clinical response and clinical remission in patients with ulcerative colitis treated with the anti-mucosal addressin cell adhesion molecule-1 (MAdCAM-1) antibody ontamalimab (SHP647): results from the open-label extension study TURANDOT II

Silvio Danese, William Sandborn, Walter Reinisch, Xavier Hebuterne, Maria Kłopocka, Dino Tarabar, Tomáš Vaňásek, Miloš Greguš, Paul A Hellstern, Joo Sung Kim, Miles P. Sparrow, Kenneth Gorelick, Martina Goetsch, Caleb Bliss, Charu Gupta, Fabio Cataldi, Severine Vermeire

MAGNETIC RESONANCE ENTEROGRAPHY DEPLOYMENT IN AN INTERNATIONAL MULTICENTRE CLINICAL TRIAL OF VEDOLIZUMAB IN CROHN'S DISEASE: AN ANALYSIS OF TECHNICAL FEASIBILITY FROM THE VERSIFY TRIAL

Jordi Rimola, Daniel Vas, Silvio Danese, Cong Han, Ozlem Yardibi, Stephen Jones, Jenifer Siegelman

Item 1 - 10 / 66
1
2 3 4 5 6 7